Literature DB >> 17245470

Effects of valproate on serotonin-induced intracellular calcium mobilization in human platelets.

Tatsuyuki Akimoto1, Ichiro Kusumi, Katsuji Suzuki, Takuya Masui, Tsukasa Koyama.   

Abstract

OBJECTIVE: Valproate (VPA) is effectively used in the treatment of bipolar disorder, although the mechanism of action is unclear. In patients with bipolar disorder, 5-hydroxytryptamine (5-HT)-induced intraplatelet calcium (Ca) mobilization has been shown to be enhanced.
METHODS: We examined the effect of VPA on 5-HT-induced Ca response in the platelets of normal subjects, in the presence of a calmodulin antagonist W-7 (N-[6-aminohexyl]-5-chloro-1-naphthalenesulfonamide), a protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA) or PKC inhibitors staurosporine and bisindolylmaleimide II.
RESULTS: VPA inhibited the 5-HT-induced Ca response in a concentration-dependent manner. For calmodulin pathways, W-7 enhanced the 5-HT-stimulated Ca response, which was not affected by VPA. For PKC pathways, PMA reduced the Ca response, although both PKC inhibitors had no effect. PMA, staurosporine or bisindolylmaleimide II reversed the inhibitory effect of VPA on the Ca response, while W-7 did not modify it.
CONCLUSION: These findings suggest the possibility that the mechanism of action of VPA may be partly related to PKC signalling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17245470      PMCID: PMC1764542     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  29 in total

Review 1.  Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness.

Authors:  H K Manji; R H Lenox
Journal:  Biol Psychiatry       Date:  1999-11-15       Impact factor: 13.382

2.  Serotonin-induced platelet intracellular calcium mobilization in various psychiatric disorders: is it specific to bipolar disorder?

Authors:  K Suzuki; I Kusumi; Y Sasaki; T Koyama
Journal:  J Affect Disord       Date:  2001-05       Impact factor: 4.839

3.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

4.  Altered 5-HT-induced calcium response in the presence of staurosporine in blood platelets from bipolar disorder patients.

Authors:  Katsuji Suzuki; Ichiro Kusumi; Tatsuyuki Akimoto; Yuki Sasaki; Tsukasa Koyama
Journal:  Neuropsychopharmacology       Date:  2003-04-02       Impact factor: 7.853

5.  Reversal by protein kinase C inhibitor of suppressive actions of phorbol-12-myristate-13-acetate on polyphosphoinositide metabolism and cytosolic Ca2+ mobilization in thrombin-stimulated human platelets.

Authors:  T Tohmatsu; H Hattori; S Nagao; K Ohki; Y Nozawa
Journal:  Biochem Biophys Res Commun       Date:  1986-01-29       Impact factor: 3.575

Review 6.  Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action.

Authors:  W Löscher
Journal:  Prog Neurobiol       Date:  1999-05       Impact factor: 11.685

7.  Treatment response in depressed patients with enhanced Ca mobilization stimulated by serotonin.

Authors:  I Kusumi; K Suzuki; Y Sasaki; K Kameda; T Koyama
Journal:  Neuropsychopharmacology       Date:  2000-12       Impact factor: 7.853

8.  Effects of lithium and valproate on agonist-induced platelet intracellular calcium mobilization: relevance to myosin light chain kinase.

Authors:  Katsuji Suzuki; Ichiro Kusumi; Tatsuyuki Akimoto; Yuki Sasaki; Tsukasa Koyama
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2004-01       Impact factor: 5.067

9.  Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain.

Authors:  Francesca Bosetti; Gayani R Weerasinghe; Thad A Rosenberger; Stanley I Rapoport
Journal:  J Neurochem       Date:  2003-05       Impact factor: 5.372

10.  N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation.

Authors:  H Hidaka; Y Sasaki; T Tanaka; T Endo; S Ohno; Y Fujii; T Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

View more
  2 in total

1.  Decreased levels of canonical transient receptor potential channel 3 protein in the rat cerebral cortex after chronic treatment with lithium or valproate.

Authors:  Sasan Zaeri; Shirin Farjadian; Masoumeh Emamghoreishi
Journal:  Res Pharm Sci       Date:  2015 Sep-Oct

2.  Evaluation of effects of various drugs on platelet functions using phorbol 12-myristate 13-acetate-induced megakaryocytic human erythroid leukemia cells.

Authors:  Tomoki Tada; Kensaku Aki; Wataru Oboshi; Kazuyoshi Kawazoe; Toshiyuki Yasui; Eiji Hosoi
Journal:  Drug Des Devel Ther       Date:  2016-09-26       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.